phenethyl isothiocyanate has been researched along with Multiple Myeloma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Anderson, KC; Blotta, S; Cervi, D; Cholujova, D; Daley, JF; Delmore, J; Hideshima, T; Jakubikova, J; Kim, K; Klippel, S; Leiba, M; McMillin, DW; Mitsiades, CS; Nahar, S; Negri, J; Ooi, M; Richardson, PG; Sedlak, J | 1 |
1 other study(ies) available for phenethyl isothiocyanate and Multiple Myeloma
Article | Year |
---|---|
Anti-tumor activity and signaling events triggered by the isothiocyanates, sulforaphane and phenethyl isothiocyanate, in multiple myeloma.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Line; Cell Proliferation; Cell Survival; Disease Models, Animal; Dose-Response Relationship, Drug; Humans; Isothiocyanates; Mice; Mice, SCID; Multiple Myeloma; Signal Transduction; Stromal Cells; Sulfoxides; Thiocyanates; Tumor Burden; Xenograft Model Antitumor Assays | 2011 |